That’s what Buster Olney is saying the Marlins are saying. And I can only think that the reason the Marlins are saying that is because the Braves — a division and geographic rival — are the team that has been mentioned with the greatest interest in the Ross.
Don’t get me wrong, Ross is a nice player. But he’s not worth a king’s ransom. For the Marlins to be saying he is is because (a) they really do want to make the Braves pay through the nose for him; or (b) if they do unload him to a division rival, they want to portray the haul they get in return for him in those terms, whether or not it truly is that rich a haul.
The Angels signed Japanese superstar Shohei Ohtani for a $2.3 million signing bonus last weekend. They may have damaged goods on their hands. Jeff Passan of Yahoo Sports reports that Ohtani underwent a physical that revealed a first-degree sprain of his ulnar collateral ligament. As a result, he got a platelet-rich plasma injection on October 20. This was made known to teams after Ohtani entered MLB’s posting system, so it wasn’t like the Angels went into this blind.
Ohtani’s report said, “Although partial damage of UCL in deep layer of his right UCL exists, he is able to continue full baseball participation with sufficient elbow care program.” It also said Ohtani “will most likely be available to start his throwing program approximately a month from the PRP.”
Passan notes that the report also mentioned that a “small free body” floats in Ohtani’s elbow near his UCL.
Ohtani isn’t without other injuries. He battled hamstring and ankle issues throughout 2017 and underwent right ankle surgery back in October. Thankfully for the Angels, this diagnosis is about as good as it could be considering the circumstances. However, if Ohtani does exacerbate his UCL issue, he may ultimately need Tommy John surgery at some point, which would take him out of action for at least a year.